Tag Archive for: Pharmacy Benefit Managers
https://pioneerinstitute.org/wp-content/uploads/drug_cost.png 512 1000 William Smith https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png William Smith2022-11-02 12:50:442022-11-02 12:54:47Is CHIA’s Drug Cost Data Reliable?
Earlier this year, the Center for Health Information and Analysis (CHIA) released its Annual Report on the Performance of the Massachusetts Health Care System for 2020. The Massachusetts Legislature relies on CHIA data when considering bills to regulate drug costs and prices. The advocacy group Health Care for All reported that CHIA data showed prescription drug spending grew by 7.7 percent in 2020, more than twice the benchmark - but the most reliable data on prescription drugs indicates that spending in 2020 was essentially flat.
https://pioneerinstitute.org/wp-content/uploads/Hubwonk-Template-72.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2022-04-12 09:55:002022-04-12 10:43:34Pharmacy Benefit Profiteers: Distortions and Costs of Half-Trillion Dollar Drug Middlemen
Hubwonk Host Joe Selvaggi talks with ALVA10 Chief Executive Hannah Mamuszka and Dr. Blake Long about the perverse incentives imposed by Pharmacy Benefit Managers adding nearly $500 billion to U.S. drug costs.
https://pioneerinstitute.org/wp-content/uploads/Untitled-1024-×-512-px.png 512 1024 William Smith https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png William Smith2022-04-04 14:21:022022-04-04 14:21:02Comments on How Pharmacy Benefit Managers (PBMs) affect Smaller Pharmacies and Consumers (ID FTC-2022-0015-0001)
Pioneer Institute Senior Fellows William Smith and Robert Popovian submitted public comments about PBM business practices to the Federal Trade Commission (FTC). Pioneer recommended that PBM discounts be passed along to patients when they are meeting their deductible or coinsurance requirements.